NCT05227326 |
AOH1996 for the Treatment of Refractory Solid Tumors |
NCT05267626 |
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT06130826 |
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer |
NCT05156866 |
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer |
NCT06090266 |
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents |
NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
NCT05325866 |
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression |
NCT05485974 |
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation |
NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
NCT05634720 |
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer |
NCT06100874 |
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) |
NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
NCT06383026 |
Transgender and Gender-Diverse Breast Cancer Screening Pilot |
NCT04990726 |
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors |
NCT05268666 |
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
NCT05111574 |
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery |
NCT05851365 |
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer |
NCT05990426 |
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy |
NCT05579366 |
PRO1184 for Advanced Solid Tumors |
NCT05806931 |
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer |
NCT02016248 |
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
NCT04052048 |
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer |
NCT05464030 |
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) |
NCT04841148 |
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer |
NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
NCT05799248 |
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management |
NCT04240327 |
Marker Driven Selection of Patients for Prostate Biopsy and Management |
NCT04896073 |
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) |
NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
NCT06450873 |
Turkey Tail Mushroom for Treating Post-Menopausal Women with HER2-Negative ER-Positive Breast Cancer Undergoing Surgery |
NCT05812027 |
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors |
NCT05340673 |
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer |
NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
NCT06608927 |
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT04387227 |
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
NCT04471727 |
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) |
NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
NCT04175431 |
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
NCT05444231 |
Breaking Through the Brain Fog: An Online Research Study |
NCT04533373 |
Sensory Restoration After DIEP Flap Neurotization |
NCT04239573 |
Comparing Two Methods to Follow Patients With Pancreatic Cysts |
NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
NCT06318273 |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
NCT06426927 |
PeLear CCC: Proyecto Latino Contra Cancer Colorrectal |
NCT05546827 |
PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma |
NCT06620627 |
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection |
NCT04903873 |
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors |
NCT05276973 |
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer |
NCT04813627 |
Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy |
NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT06646627 |
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors |
NCT05311527 |
UroLift System With SAbR for Prostate Cancer and BPH |
NCT05456373 |
Intraoperative Use of ClearEdge Device in Breast Conserving Surgery |
NCT06081127 |
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function |
NCT06671782 |
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy |
NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
NCT06428682 |
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction |
NCT06202820 |
CV CARE: CardioVascular Care in PC Patients |
NCT06270082 |
Study of IK-595 in RAS- or RAF-altered Advanced Tumors |
NCT03127631 |
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients |
NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
NCT05669482 |
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer |
NCT05941520 |
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
NCT06146920 |
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation |
NCT04421820 |
BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours |
NCT06106282 |
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) |
NCT05653882 |
A Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors |
NCT04837820 |
The Effect of Acupuncture on Cancer-Related Cognitive Difficulties |
NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
NCT05828082 |
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer |
NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies |
NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
NCT05006131 |
Pancreatic Cancer Screening for At-risk Individuals |
NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
NCT04297020 |
Brain Health in Breast Cancer Survivors |
NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
NCT04335682 |
Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide |
NCT06402331 |
FPI-2265 (225Ac-PSMA-I&T) for Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
NCT04569773 |
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer |
NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
NCT05722327 |
Phase I Trial of Adagrasib (MRTX849) in Combination with Cetuximab and Irinotecan in Patients with Colorectal Cancer |
NCT02861573 |
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) |
NCT06141031 |
Trial of Radiotherapy in Combination with TTI-101 in Patients with Borderline Resectable Pancreatic Cancer |
NCT06188520 |
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors |
NCT06003231 |
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 |
NCT04692831 |
Testing a New Imaging Agent to Identify Cancer |
NCT05563220 |
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer |
NCT05568420 |
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC) |
NCT05929820 |
Impact of Protect Your Colon™ on CRC Screening |
NCT05029882 |
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab |
NCT06340620 |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope |
NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
NCT05994482 |
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study |
NCT06253182 |
Psychosexual Educational Partners Program (PEPP) |
NCT05736731 |
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants with Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression |
NCT05869682 |
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy |
NCT05961982 |
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study |
NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
NCT00898131 |
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer |
NCT04815876 |
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2 |
NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
NCT06339827 |
ASk Questions in GYnecologic Oncology (ASQ-GYO) |
NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
NCT04701476 |
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC |
NCT04709276 |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer |
NCT06625320 |
Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT06437574 |
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer |
NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
NCT04567420 |
DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT05585320 |
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors |
NCT06216574 |
Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial |
NCT05470920 |
Genetic Testing Decision Aid |
NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
NCT05115474 |
Study of Screening Brain MRIs in Stage IV Breast Cancer |
NCT05799274 |
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer |
NCT05411094 |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
NCT05691491 |
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness |
NCT05477576 |
Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy |
NCT04808427 |
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer |
NCT03955627 |
REJOIN Trial for Older Breast Cancer Survivors |
NCT04104776 |
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas |
NCT04541108 |
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies |
NCT06084338 |
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc |
NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
NCT06216938 |
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis |
NCT04844073 |
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer |
NCT03161431 |
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab |
NCT05903131 |
A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia |
NCT06392789 |
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors |
NCT06485089 |
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers |
NCT04840589 |
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors |
NCT05367440 |
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer |
NCT00001276 |
Diagnosing and Treating Low Blood Sugar Levels |
NCT06312176 |
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) |
NCT05269160 |
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer and Head and Neck Cancer Patients (TOPAZ) |
NCT05995860 |
Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery |
NCT06599476 |
Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy |
NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
NCT05912231 |
Ultrahypofractionation and Normal Tissue Toxicity |
NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers |
NCT04873362 |
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy |
NCT06568562 |
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05797831 |
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer |
NCT05000294 |
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types |
NCT05633160 |
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) |
NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
NCT05627960 |
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
NCT04754191 |
Enfortumab Vedotin As Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer |
NCT05629494 |
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test |
NCT04473794 |
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts |
NCT06396091 |
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer |
NCT06056791 |
Study of INKmune in Patients With mCRPC (CaRe Prostate) |
NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
NCT03485794 |
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer |
NCT04147494 |
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues |
NCT05604560 |
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer |
NCT06432660 |
Eye Plaque Brachytherapy for Ocular Melanoma |
NCT05593094 |
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors |
NCT00991094 |
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated with Proton Therapy |
NCT03073694 |
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis |
NCT06239194 |
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors |
NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
NCT05613894 |
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT04324294 |
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions |
NCT03746431 |
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection |
NCT04353973 |
Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients |
NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
NCT04134260 |
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer |
NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
NCT06387173 |
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer |
NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
NCT05591131 |
Genetic Testing in African Americans |
NCT05611931 |
Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma |
NCT05888831 |
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors |
NCT06471673 |
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer |
NCT06294873 |
Stool Sample Collection Study |
NCT06595160 |
Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma |
NCT04394676 |
The Impact of Low Pressure Pneumo in RARP II |
NCT05721976 |
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study |
NCT05968157 |
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick |
NCT06336148 |
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors |
NCT02632448 |
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer |
NCT05673148 |
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study |
NCT05842057 |
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy |
NCT03659448 |
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer |
NCT04991948 |
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
NCT06137248 |
Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption |
NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
NCT05085548 |
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies |
NCT06249048 |
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
NCT03351348 |
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control |
NCT05721248 |
STOP-HER2: Stopping Trastuzumab in HER2+ MBC |
NCT04443348 |
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) |
NCT04673448 |
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer |
NCT06358430 |
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) |
NCT03972657 |
A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors |
NCT05526248 |
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide |
NCT06068257 |
Tumor-Derived FGF19 |
NCT06557148 |
A Study Comparing Cancer Imaging Approaches in People with Lobular Breast Cancer |
NCT05752448 |
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) |
NCT05766748 |
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer |
NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
NCT05488548 |
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies |
NCT05053230 |
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer |
NCT05501548 |
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer |
NCT04545957 |
Jump: MR Simulation For Radiation Therapy Master Protocol |
NCT06399757 |
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors |
NCT03558048 |
The Effect of IBD Flares on Serum PSA |
NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
NCT05948657 |
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr |
NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
NCT02884648 |
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery |
NCT05020574 |
Microbiome and Association With Implant Infections |
NCT06376565 |
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps |
NCT04449874 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation |
NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
NCT05305365 |
Study Assessing QBS72S for Treating Brain Metastases |
NCT05931874 |
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors |
NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
NCT05209074 |
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma |
NCT06549465 |
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer |
NCT04565457 |
A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality |
NCT03568448 |
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging |
NCT06675357 |
Using FAPI PET/MRI to Evaluate Prostate Cancer |
NCT04248257 |
Peer Support For Young Adult Women With High Breast Cancer Risk |
NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
NCT05056857 |
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen |
NCT02595957 |
Genomic Services Research Program |
NCT05744557 |
Vapocoolant Analgesia for Breast Lymphoscintigraphy |
NCT02910557 |
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection |
NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
NCT06590857 |
Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs |
NCT00830557 |
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders |
NCT06044857 |
PSMA PET Response Guided SabR in High Risk Pca |
NCT06586957 |
A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors |
NCT04275557 |
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
NCT06324357 |
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread |
NCT06463457 |
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) |
NCT05952557 |
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) |
NCT06639074 |
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial |
NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
NCT05631574 |
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer |
NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
NCT06441474 |
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
NCT03090165 |
Ribociclib and Bicalutamide in AR+ TNBC |
NCT00756665 |
Prostate Active Surveillance Study |
NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
NCT03538665 |
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons |
NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
NCT05289466 |
Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation. |
NCT05045066 |
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients |
NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
NCT06465966 |
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning |
NCT05592626 |
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors |
NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
NCT04198766 |
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) |
NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
NCT05674526 |
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab |
NCT05868226 |
PRE-I-SPY Phase I/Ib Oncology Platform Program |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer |
NCT05491226 |
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation |
NCT06423326 |
Gemcitabine, Cisplatin and Nab-Paclitaxel As Neoadjuvant Treatment for Patients with Resectable or Borderline Resectable Pancreatic Cancer |
NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
NCT04609566 |
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors |
NCT00899626 |
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients |
NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT06378866 |
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial |
NCT04590326 |
A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 |
NCT05391126 |
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
NCT05756166 |
Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer |
NCT06295965 |
Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers, CHANCES Study |
NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
NCT03048266 |
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients |
NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
NCT06508827 |
Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma |
NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
NCT06399276 |
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity |
NCT04666727 |
Role of Diet on the Microbiome of the Digestive System |
NCT06253520 |
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer |
NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
NCT05902520 |
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors |
NCT05047926 |
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients |
NCT02610426 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer |
NCT04140526 |
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC |
NCT03745326 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients |
NCT05948826 |
First in Human Study of TORL-3-600 in Participants With Advanced Cancer |
NCT06420726 |
Resistance Exercise and Creatine in Colorectal Cancer |
NCT06297525 |
Study of STP938 in Advanced Solid Tumours |
NCT06056830 |
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy |
NCT03696030 |
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT05922930 |
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer |
NCT02760030 |
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery |
NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
NCT06671730 |
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer |
NCT03568630 |
Blood Markers of Early Pancreas Cancer |
NCT04616248 |
In Situ Immunomodulation with CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients W/ Unresectable and Metastatic Solid Tumors |
NCT05870748 |
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 |
NCT03767348 |
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab |
NCT06307548 |
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer |
NCT05461430 |
Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx) |
NCT05223322 |
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction |
NCT04633239 |
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer |
NCT06171139 |
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer |
NCT03104439 |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer |
NCT04008030 |
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) |
NCT06734130 |
Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer |
NCT04973930 |
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer |
NCT05283330 |
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors |
NCT03697148 |
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer |
NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer |
NCT06449222 |
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy |
NCT05231122 |
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer |
NCT05720039 |
Robotic Vs. Open NSM for Early Stage Breast Cancer |
NCT02960022 |
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
NCT04794322 |
Developing a Test for the Detection of Ovarian Cancer |
NCT05400122 |
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer |
NCT03880422 |
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors |
NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma |
NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
NCT04175210 |
Prospective Randomized Study of Accelerated Radiation Therapy (PRART) |
NCT05043012 |
Diagnostic Performance of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging of Prostate with Flexible AIR Coil (DoNEMAC Study) |
NCT05999812 |
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer |
NCT05730712 |
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT05049746 |
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
NCT05230810 |
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
NCT05462314 |
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies |
NCT03699995 |
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma |
NCT02912312 |
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer |
NCT02170181 |
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation |
NCT06036810 |
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy |
NCT05414812 |
Intervening on Women's Health for Rural Young Breast Cancer Survivors |
NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
NCT04098081 |
1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma |
NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer |
NCT04877912 |
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening |
NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
NCT06408168 |
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) |
NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
NCT03801369 |
Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer |
NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
NCT06011772 |
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer |
NCT05194072 |
A Study of SGN-B7H4V in Advanced Solid Tumors |
NCT04668872 |
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation |
NCT04225572 |
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) |
NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
NCT04594772 |
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma |
NCT05132504 |
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT04657068 |
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors |
NCT03860272 |
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer |
NCT04739072 |
Minimal Residual Disease Assessment in Patients with Colorectal Cancer, the MiRDA-C Study |
NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
NCT05415072 |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
NCT03692429 |
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells |
NCT06413680 |
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies |
NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer |
NCT04109729 |
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer |
NCT05710380 |
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy |
NCT05143229 |
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer |
NCT03727880 |
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma |
NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
NCT05785780 |
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings |
NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
NCT05440929 |
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians |
NCT04662580 |
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer |
NCT05896189 |
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors |
NCT06085729 |
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) |
NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
NCT05864144 |
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
NCT03919292 |
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca |
NCT03825289 |
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer |
NCT02584244 |
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers |
NCT04609592 |
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery |
NCT03734692 |
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer |
NCT06157892 |
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors |
NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases |
NCT05846789 |
Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers |
NCT04415944 |
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT04106492 |
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors |
NCT02478892 |
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk |
NCT05914792 |
Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
NCT03804944 |
Converting HR+ Breast Cancer Into an Individualized Vaccine |
NCT05578092 |
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway |
NCT04445844 |
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study |
NCT03899792 |
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors |
NCT03323944 |
CAR T Cell Immunotherapy for Pancreatic Cancer |
NCT04631744 |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
NCT06559540 |
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer |
NCT06342440 |
Early Detection of Advanced Adenomas and Colorectal Cancer |
NCT05355701 |
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. |
NCT03228667 |
QUILT-3.055: a Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment with Immune Checkpoint Inhibitors |
NCT06184867 |
Choices About Genetic Testing And Learning Your Risk With Smart Technology |
NCT06521567 |
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer |
NCT05907304 |
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations |
NCT04349501 |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
NCT04674267 |
Resilience and Equity in Aging, Cancer, and Health (REACH) |
NCT04576104 |
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer |
NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
NCT06394804 |
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer |
NCT04474301 |
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic |
NCT04994067 |
Intra-Operative Radiation Registry |
NCT01492972 |
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer |
NCT05912244 |
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma |
NCT04512144 |
Mindfulness in Endometrial and Cervical Cancer |
NCT05376592 |
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma |
NCT04731844 |
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer |
NCT05086692 |
A Beta-only IL-2 ImmunoTherapY Study |
NCT06095089 |
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer |
NCT04457089 |
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer |
NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
NCT01954992 |
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
NCT03682289 |
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors |
NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
NCT06614192 |
A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer |
NCT05472792 |
Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN) |
NCT06229392 |
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer |
NCT05735080 |
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer |
NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT04588662 |
A Prospective Natural History Study in Uveal Melanoma |
NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination with Cemiplimab in Patients with Advanced Solid Tumors and Lymphomas. |
NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
NCT06121180 |
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma |
NCT06173362 |
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer |
NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
NCT05642962 |
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
NCT03151629 |
International Registry for Men With Advanced Prostate Cancer (IRONMAN) |
NCT06651580 |
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study |
NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) |
NCT05646862 |
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy |
NCT04404894 |
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing |
NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
NCT05076760 |
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer |
NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
NCT03822494 |
CyberKnife Dose Escalation Prostate Cancer Trial |
NCT04878094 |
A Study of Intra-operative Imaging in Women With Ovarian Cancer |
NCT05478694 |
Outcomes of Focal Ablation for Prostate Cancer |
NCT06180460 |
CALM: Managing Distress in Malignant Brain Cancer |
NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
NCT05396794 |
Bariatric Education for Women With Obesity and Endometrial Cancer |
NCT05665660 |
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening |
NCT06152276 |
SafeHeal Diverting Ileostomy Pivotal Study |
NCT04550494 |
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations |
NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
NCT02400060 |
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer |
NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer |
NCT06550791 |
Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors |
NCT06638294 |
Study in Patients With Breast Cancer Leptomeningeal Metastasis |
NCT05910294 |
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer |
NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
NCT05020860 |
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer |
NCT03876860 |
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis |
NCT06179160 |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
NCT01441089 |
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis |
NCT05919329 |
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy |
NCT05625529 |
ExoLuminate Study for Early Detection of Pancreatic Cancer |
NCT04919629 |
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion |
NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
NCT05620329 |
UNC Pleural Fluid Registry |
NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
NCT05932862 |
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors |
NCT06252662 |
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies |
NCT04561362 |
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies |
NCT06445062 |
Study of RAS(ON) Inhibitors in Patients with Gastrointestinal Solid Tumors |
NCT04684862 |
Infusion System for Hepatic Cancer |
NCT03789162 |
Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast |
NCT05304962 |
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
NCT00539162 |
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women |
NCT04706962 |
TH1902 in Patients With Advanced Solid Tumors |
NCT06447662 |
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. |
NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
NCT05704062 |
Quantitative MRI Assessment of Breast Cancer Therapy Response |
NCT03991962 |
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma |
NCT05731791 |
Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation |
NCT05959291 |
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer |
NCT06315491 |
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer |
NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
NCT03971591 |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
NCT05629546 |
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors |
NCT04812912 |
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer |
NCT06168812 |
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer |
NCT06369246 |
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer |
NCT06074510 |
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer |
NCT06026410 |
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors |
NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
NCT05369546 |
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
NCT04541381 |
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care |
NCT05248581 |
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases |
NCT06568692 |
A Phase 2 Study of PCS6422 with Capecitabine in Patients with Advanced or Metastatic Breast Cancer |
NCT06566092 |
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants |
NCT01766492 |
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery |
NCT06538389 |
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer |
NCT06481592 |
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. |
NCT03567889 |
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients |
NCT04514692 |
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging |
NCT03270072 |
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients |
NCT04829604 |
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) |
NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
NCT02863172 |
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes |
NCT05691504 |
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
NCT04691804 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05654246 |
Susan G. Komen's ShareForCures |
NCT05563272 |
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors |
NCT05067140 |
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer |
NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
NCT05554367 |
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial |
NCT02628067 |
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) |
NCT04956640 |
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) |
NCT05032040 |
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies |
NCT05688280 |
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS |
NCT06271291 |
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
NCT03233191 |
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer |
NCT05683691 |
Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer |
NCT05608291 |
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery |
NCT04930991 |
High Dose Omeprazole in Patients With Pancreatic Cancer |
NCT05467891 |
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer |
NCT06594991 |
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma |
NCT05562791 |
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer |
NCT04839991 |
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. |
NCT06120491 |
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents |
NCT06323291 |
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study |
NCT06245889 |
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC |
NCT06171789 |
PRO1107 in Patients With Advanced Solid Tumors |
NCT02735746 |
Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis |
NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
NCT04854304 |
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts |
NCT05094804 |
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents |
NCT04868604 |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
NCT06120972 |
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency |
NCT05652686 |
A Study of PT217 in Patients with Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) |
NCT06014086 |
Intratumoral PH-762 for Cutaneous Carcinoma |
NCT06037863 |
Evaluation of the Impact of Empty Versus Full Bladder in Patients with Prostate Cancer, RELIEF Trial |
NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
NCT06479239 |
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer |
NCT03589339 |
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy |
NCT04707248 |
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors |
NCT06262139 |
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients |
NCT04496739 |
Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE) |
NCT06246786 |
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer) |
NCT06300463 |
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases |
NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
NCT03987386 |
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer |
NCT06193486 |
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC |
NCT06055439 |
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy |
NCT05832086 |
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes |
NCT06353386 |
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) |
NCT05525286 |
Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma |
NCT04927663 |
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression |
NCT04575935 |
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial |
NCT06542835 |
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity |
NCT06250335 |
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients |
NCT06500858 |
MBC Physical Activity Study |
NCT02743858 |
Lymphedema Surveillance Study |
NCT03960463 |
EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds |
NCT06059963 |
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation |
NCT05528263 |
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) |
NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
NCT03420963 |
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors |
NCT06287463 |
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway |
NCT04115163 |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT04440735 |
A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors |
NCT05754658 |
African Cancer Genome: GMD |
NCT04847063 |
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies |
NCT05428735 |
The DRAGON 2 Trial |
NCT04074135 |
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors |
NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
NCT04887935 |
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
NCT05453825 |
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors |
NCT05722925 |
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET |
NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
NCT06654622 |
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer. |
NCT05238922 |
Study of INCB123667 in Subjects With Advanced Solid Tumors |
NCT05256225 |
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Cancer |
NCT06022822 |
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
NCT03333122 |
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes |
NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
NCT05051722 |
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer |
NCT05605522 |
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours |
NCT04430725 |
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study |
NCT05928325 |
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment |
NCT06388122 |
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients |
NCT06294886 |
Vaginal Fluid Collection for Detection of Endometrial Cancer |
NCT06389786 |
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer |
NCT03129139 |
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors |
NCT05707286 |
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy |
NCT01937039 |
Johns Hopkins Breast Cancer Program Longitudinal Repository |
NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
NCT05574686 |
Telemonitoring Hypertension and Breast Cancer |
NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
NCT04797039 |
MRI-Guided Cryoablation for Focal Native Prostate Cancer |
NCT04721886 |
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer |
NCT03546686 |
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women with Triple-negative Breast Cancer |
NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
NCT05571839 |
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors |
NCT05478239 |
ArtemiCoffee in Patients With Rising PSA |
NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
NCT05501886 |
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) |
NCT05810025 |
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments |
NCT06385925 |
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation |
NCT05634525 |
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients |
NCT00451022 |
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies |
NCT05004025 |
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma |
NCT06044025 |
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
NCT06119425 |
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands |
NCT03203525 |
Combination Chemotherapy and Bevacizumab with the NovoTTF-100L(P) System in Treating Participants with Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer |
NCT05669430 |
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination with Pembrolizumab in Participants with Solid Tumor Malignancies |
NCT05553522 |
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer |
NCT06125522 |
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) |
NCT06128525 |
Prostate Resection After Microwave Ablation (PRAMA) |
NCT02872025 |
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS) |
NCT01915225 |
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer |
NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
NCT04263025 |
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft |
NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients with Breast Cancer |
NCT04444622 |
Immunotherapy for Third Line Metastatic Colorectal Cancer |
NCT02896335 |
Palbociclib and Pembrolizumab in Central Nervous System Metastases |
NCT04188535 |
Serial MRI Scans During Radiation Therapy |
NCT03526835 |
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors |
NCT06421935 |
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) |
NCT03821935 |
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors |
NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
NCT05768139 |
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
NCT04511039 |
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer |
NCT06400563 |
MRg-NIRS Imaging System Breast Cancer Trial |
NCT05375539 |
AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients |
NCT06129422 |
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer |
NCT06028022 |
Reishi Mushroom Extract for Fatigue And/or Arthralgias/myalgias in Patients with Breast Cancer on Aromatase Inhibitors |
NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
NCT03716739 |
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency |
NCT05539430 |
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma |
NCT05538130 |
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors |
NCT05877430 |
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
NCT03991130 |
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma |
NCT04941430 |
7T MRI Scan for the Early Detection of Melanoma Brain Metastases |
NCT05764330 |
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance |
NCT03147430 |
Early Detection of Breast Cancer in Women With Suspicious Mammograms |
NCT03524430 |
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy |
NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic Cancer |
NCT05573126 |
Phase 1/2 Study to Evaluate EP0062 in Patients With Relapsed Locally Advanced or Metastatic Androgen Receptor Positive (AR+)/HER2-/ER+ Breast Cancer |
NCT06314958 |
Stage II/III Colorectal Cancer Recurrence |
NCT02307058 |
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy |
NCT04961996 |
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) |
NCT06590558 |
Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer |
NCT06001658 |
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers |
NCT06315296 |
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer |
NCT05841355 |
Empowering Latinas to Obtain Guideline Concordant Screenings |
NCT06612281 |
Evaluation of Gixam's Performance in a FIT Negative Population |
NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
NCT04866810 |
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN) |
NCT05655312 |
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma |
NCT06369610 |
Risk Stratified De-escalated Hormone Therapy with Radiation Therapy for the Treatment Prostate Cancer |
NCT05396612 |
Role of the Immune Environment in Response to Therapy in Breast Cancer |
NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
NCT05479812 |
Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors |
NCT05296512 |
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer |
NCT05241210 |
Real-Time Feedback (RTFB) to Improve Colonoscopy |
NCT05082610 |
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors |
NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
NCT02927912 |
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction |
NCT05417867 |
Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer |
NCT05867667 |
Cardiac Rehabilitation to Improve Breast Cancer Outcomes |
NCT02484404 |
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... |
NCT06129604 |
Pilot Window of Opportunity Trial (POET) |
NCT05046301 |
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications |
NCT04042701 |
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer |
NCT04648904 |
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer |
NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
NCT02772367 |
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients |
NCT04580667 |
Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma |
NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
NCT03846167 |
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT |
NCT06388967 |
Pancreatic Cancer Detection Consortium |
NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
NCT06643767 |
Evaluation of the Bexa Breast Examination |
NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT05703269 |
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy |
NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
NCT02332668 |
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) |
NCT02526368 |
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer |
NCT06465368 |
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause |
NCT04589468 |
Researching the Effect of Exercise on Cancer |
NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT05789069 |
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors |
NCT04670068 |
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian |
NCT05838768 |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
NCT03460769 |
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) |
NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy |
NCT05751668 |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
NCT04644068 |
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies |
NCT01102569 |
Pancreatic Cancer Genetics |
NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
NCT04314401 |
National Cancer Institute "Cancer Moonshot Biobank" |
NCT05705401 |
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer |
NCT06342401 |
Early Onset Colorectal Cancer Detection |
NCT05795101 |
TRUDI: TDXD+Durva in HER2+/low IBC |
NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
NCT04104672 |
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies |
NCT05924672 |
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients |
NCT05023967 |
Metformin and Nightly Fasting in Women With Early Breast Cancer |
NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
NCT04783467 |
Time Restricted Eating (TRE) Among Endometrial Cancer Patients |
NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
NCT03564340 |
Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT04339140 |
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer |
NCT05523440 |
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation |
NCT05968144 |
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness |
NCT02701244 |
A Registry Study of Breast Microseed Treatment |
NCT06295744 |
Outcomes and Cosmesis With Whole Breast Irradiation and Boost |
NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
NCT05345444 |
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) |
NCT05887492 |
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors |
NCT05726292 |
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer |
NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
NCT05113368 |
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer |
NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
NCT04687969 |
Multimodal Machine Learning Characterization of Solid Tumors |
NCT05215769 |
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer |
NCT05546268 |
Study of Oral MRT-2359 in Selected Cancer Patients |
NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
NCT06465069 |
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors |
NCT04426669 |
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering |
NCT05469269 |
Cleveland African American Prostate Cancer Project |
NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
NCT06215469 |
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) |
NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial |
NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
NCT06171269 |
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life |
NCT04905069 |
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy |
NCT05318469 |
Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer |
NCT04636710 |
Refining Local-Regional Therapy for IBC |
NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
NCT06325046 |
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer |
NCT04291612 |
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease |
NCT06518746 |
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation |
NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT05218044 |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ |
NCT05877144 |
LiSWT for Nerve Sparing Radical Prostatectomy ED |
NCT06562192 |
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers |
NCT05537740 |
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors |
NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
NCT04007744 |
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors |
NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
NCT02402244 |
Project: Every Child for Younger Patients With Cancer |
NCT04703244 |
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer |
NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
NCT04009044 |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast |
NCT04787744 |
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer |
NCT06710067 |
Urine Metabolites in the Diagnosis of Disease |
NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT06361940 |
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients with Hormone Receptor-Positive HER2-negative Breast Cancer |
NCT06046040 |
TmPSMA-02 in mCRPC |
NCT06346067 |
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) |
NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
NCT05581004 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors |
NCT06376604 |
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies |
NCT06326216 |
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer |
NCT06364696 |
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors |
NCT05914116 |
A Study of DB-1311 in Advanced/Metastatic Solid Tumors |
NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
NCT05715216 |
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer |
NCT04794816 |
What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care |
NCT05232916 |
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects |
NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma |
NCT04568616 |
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
NCT06113016 |
Prevention of Frailty with Fisetin and Exercise (PROFFi) in Breast Cancer Survivors |
NCT05383196 |
Onvansertib + Paclitaxel in TNBC |
NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
NCT05013216 |
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer |
NCT06551324 |
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). |
NCT05548296 |
A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma |
NCT06205316 |
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma |
NCT05252416 |
(VELA) Study of BLU-222 in Advanced Solid Tumors |
NCT05627635 |
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer |
NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
NCT04533763 |
Living WELL: A Web-Based Program for Ovarian Cancer Survivors |
NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
NCT06132958 |
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) |
NCT04715958 |
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer |
NCT05142358 |
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
NCT00291096 |
Protocol for Women at Increased Risk of Developing Breast Cancer |
NCT05377996 |
A Study of XMT-1660 in Participants With Solid Tumors |
NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer |
NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
NCT05576896 |
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory |
NCT06090916 |
Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer |
NCT03467516 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma |
NCT06298916 |
64Cu-LNTH-1363S in Patients with Sarcoma or Gastrointestinal Tract Cancer |
NCT06584396 |
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study |
NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
NCT00034216 |
Collection of Blood From Patients With Cancer |
NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
NCT05946824 |
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. |
NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
NCT04830124 |
Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 |
NCT06208124 |
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors |
NCT05036096 |
Cone Beam Breast CT for Breast Cancer Screening |
NCT03819296 |
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer |
NCT04975516 |
Standard of Care Chemotherapy with or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer |
NCT06703996 |
InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors |
NCT05930496 |
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors |
NCT06136624 |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) |
NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
NCT05268224 |
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue |
NCT05316324 |
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction |
NCT02611024 |
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors |
NCT05812924 |
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause |
NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer |
NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
NCT05748834 |
Study of Tucatinib and Doxil in Participants with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
NCT04711824 |
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
NCT03772834 |
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients with Prostate Cancer |
NCT06219434 |
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer |
NCT04898634 |
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer |
NCT05497024 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing |
NCT04267796 |
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women |
NCT04457596 |
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial |
NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
NCT04243616 |
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer |
NCT04130516 |
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab |
NCT04331535 |
The Genomic Medicine at VA Study |
NCT06623396 |
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer |
NCT06084416 |
A Study of Sovilnesib in Subjects with Ovarian Cancer |
NCT06566716 |
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women With an Ovarian Mass |
NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
NCT05692596 |
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics |
NCT04996316 |
MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals |
NCT05356117 |
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial |
NCT06067841 |
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer |
NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
NCT06582017 |
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
NCT05838417 |
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study |
NCT05565417 |
Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas |
NCT06117241 |
Reducing Metabolic Dysregulation in Dyads |
NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
NCT04825834 |
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) |
NCT05743517 |
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) |
NCT06486441 |
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) |
NCT06384417 |
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 |
NCT06379217 |
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
NCT05465941 |
PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer |
NCT05415917 |
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy |
NCT06150417 |
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) |
NCT06579417 |
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer |
NCT05803941 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
NCT06391034 |
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer |
NCT06466434 |
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma |
NCT05852041 |
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance |
NCT05785741 |
A Study of DB-1310 in Advanced/Metastatic Solid Tumors |
NCT05514717 |
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 |
NCT00912717 |
Pancreatic Adenocarcinoma Gene Environment Risk Study |
NCT03987217 |
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients |
NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
NCT04548817 |
Neurocutaneous Melanocytosis Registry |
NCT06040541 |
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors |
NCT03991741 |
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors |
NCT03820141 |
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer |
NCT05776524 |
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer |
NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy |
NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
NCT06298734 |
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial |
NCT05751434 |
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
NCT05297734 |
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer |
NCT06410534 |
A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer |
NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer. |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
NCT06291324 |
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment |
NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
NCT06274034 |
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors |
NCT05585034 |
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors |
NCT05926024 |
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment |
NCT06075524 |
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types |
NCT03965234 |
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases |
NCT06011434 |
Testing Conversation Aid in Practice |
NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
NCT04858334 |
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation |
NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
NCT04981834 |
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer |
NCT06547034 |
VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects |
NCT06388304 |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence |
NCT02279004 |
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care |
NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
NCT05396846 |
My Best GI Eating Study |
NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
NCT05058846 |
Pilot Study of Pancreatic Cancer Screening |
NCT06079346 |
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer |
NCT04354246 |
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies |
NCT05220046 |
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers |
NCT06340646 |
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
NCT05239546 |
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers |
NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
NCT05501704 |
ETHAN - ET for Male BC |
NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
NCT06014255 |
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer |
NCT05323955 |
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients with ADvanced Human Epidermal Growth Factor Receptor 2+ BrEast Cancer with the Addition of Tucatinib |
NCT05530655 |
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
NCT03709446 |
Leflunomide in Previously Treated Metastatic Triple Negative Cancers |
NCT05819255 |
TRAQinform Assessment of Immunotherapy Response |
NCT02993068 |
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT06400472 |
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors |
NCT04044872 |
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity |
NCT04890613 |
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation |
NCT04605913 |
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC |
NCT06112613 |
Mobile Health for Adherence in Breast Cancer Patients |
NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
NCT05595213 |
Wrist Cooling for Hot Flashes Clinical Trial |
NCT04485013 |
TTX-080 HLA-G Antagonist in Subjects with Advanced Cancers |
NCT05536713 |
Understanding Patient Preference on Colorectal Cancer Screening Options |
NCT06303713 |
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer |